1-9 of 9
selective estrogen receptor modulators
Close
Sort by
Journal Articles

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Smita Bhatia, MDMPH, Melanie Palomares, MD, Lindsey Hageman, MPH, Yanjun Chen, MS, Wendy Landier, PhD CRNP, Kandice Smith, RN, Heidi Umphrey, MD, Caroline A. Reich, MD PhD, Kathryn W. Zamora, MD MPH, Saro H. Armenian, DO, MPH, Therese Bartholomew Bevers, MD, Anne Blaes, MD, Tara O. Henderson, MD MPH, David C. Hodgson, MD MPH, FRCPC, Melissa M. Hudson, MD, Larissa Korde, MD, Susan A. Melin, MD, Sofia Merajver, MD PhD, Linda Overholser, MD, Sandhya Pruthi, MD, Lennie Wong, PhD, Judy Garber, MD MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 2843.
https://doi.org/10.1182/blood-2019-126661
Published: 2019
Journal Articles

Platelet and Megakaryocytic Regulation of Tumor Progression

Elisabeth M. Battinelli, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): SCI-26.
https://doi.org/10.1182/blood.V130.Suppl_1.SCI-26.SCI-26
Published: 2017
Journal Articles

Tamoxifen Directly Inhibits Platelet Activation, Angiogenic Potential and Platelet-Mediated Metastasis

Elisabeth M. Battinelli, MD PhD, Kelly Elizabeth Johnson, PhD, Jodi A Forward, Mason Tippy, BS, Rajesh Kulenthirarajan, Erica L. Mayer, MD, Joseph E Italiano, Jr., PhD
Journal: Blood
Blood (2016) 128 (22): 3723.
https://doi.org/10.1182/blood.V128.22.3723.3723
Published: 2016
Journal Articles

Noncellular Niche Influences: Nervous System Mediators, Metabolic Mediators, and Hypoxia/Oxidative Stress

Simón Méndez-Ferrer, PhD
Journal: Blood
Blood (2015) 126 (23): SCI-26.
https://doi.org/10.1182/blood.V126.23.SCI-26.SCI-26
Published: 2015
Journal Articles

Tamoxifen Directly Disrupts Platelet Angiogenic Potential and Inhibits Platelet-Mediated Metastasis

Elisabeth M. Battinelli, MD PhD, Rajesh Kulenthirarajan, Joseph E Italiano, PhD, Kelly Johnson, PhD
Journal: Blood
Blood (2014) 124 (21): 4169.
https://doi.org/10.1182/blood.V124.21.4169.4169
Published: 2014
Journal Articles

Selective G-Protein Estrogen Receptor (GPER) Activation Triggers Anti-Multiple Myeloma Activity and Synergizes with MiR-29b-Inducing Drugs

Nicola Amodio, PhD, Marzia Leotta, MD, Eugenio Morelli, MD, Teresa Calimeri, MD PhD, Anna Maria Gullà, MD, Maria Angelica Stamato, Enrica Romeo, Umberto Foresta, PhDstudent, Antonino Neri, Maria Teresa Di Martino, PhD, Pierosandro Tagliaferri, MD, Pierfrancesco Tassone, MD
Journal: Blood
Blood (2014) 124 (21): 4725.
https://doi.org/10.1182/blood.V124.21.4725.4725
Published: 2014
Journal Articles

Regulation of the Gene Encoding Human Thrombin-Activable Fibrinolysis Inhibitor by Female Sex Steroids

Mathieu Garand, M.Sc., Michael B Boffa, Ph.D., Marlys L. Koschinsky, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 3077.
https://doi.org/10.1182/blood.V112.11.3077.3077
Published: 2008
Journal Articles

Risk Factors for Clinical Manifestations in Patients with Factor V Leiden and Prothrombin Gene Mutations.

Maria Teresa De Sancho, MD, Nickisha Berlus, Jacob H. Rand, MD
Journal: Blood
Blood (2006) 108 (11): 4090.
https://doi.org/10.1182/blood.V108.11.4090.4090
Published: 2006
Journal Articles

Production of Tissue Factor Pathway Inhibitor in Endothelial Cell Cultures Is Reduced by Estrogens, Selective Estrogen Receptor Modifiers, and a Selective Estrogen Receptor Downregulator.

Anders E.A. Dahm, MD, Nina Iversen, PhD, Baard Birkenes, Per Morten Sandset, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3961.
https://doi.org/10.1182/blood.V106.11.3961.3961
Published: 2005